Wednesday’s stock decline looked like end-of-quarter kind of action, said Jack Bouroudjian, chief investment officer of Index Financial Partners. However, he thinks the real question is what will happen at the beginning of the next quarter.”One of the things that worries me is that we’re entering a very difficult time for stocks,” he told “Closing Bell.”Read More Stocks plunge, but […]
In times of high volatility, options are an incredibly valuable addition to any portfolio as part of a prudent risk-management strategy, or as a speculative, directionally neutral trade.After a trader has conducted their due diligence and enters a position, regardless of how certain they may be of the direction a volatile stock will take on, they are very much limited […]
GILD Stock Continues Recovery From Monday’s FallGilead Sciences, Inc. (NASDAQ: GILD)GILD stocks fell hard Monday; losing more than two percent as the company issued a warning to doctors treating their patients with Sovaldi in combination with antiarrhythmics. However, the slide stopped and the stock started to move in the positive direction. Today, it seems as though the stock is staying […]
The financial markets have been on the rise for the past six years. That can only mean that doom is around the corner. What financial bubble is waiting to pop, and destroy us? Today: biotech stocks.What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, […]
Echoing the grave concerns of no lesser ‘maestro’ of manipulation than Alan Greenspan, Wells Capital Management’s Jim Paulsen notes that while the U.S. stock market has risen by about 3 times from its crisis low in March 2009; much of this advance has been against a backdrop of disappointing productivity gains… should productivity growth remain subpar, stock market risk […]
Everyone likes a great deal, and there’s no biotech stock I’d love to see go on sale more than Celgene (NASDAQ: CELG).Celgene’s blockbuster drugs, industry-leading profitability, and rock-solid balance sheet put it among the elite companies in the business. As a result, the company hasn’t given investors too many chances to buy its shares at a bargain price. But if […]
Stocks came in again on Tuesday, after a morning bounce, still consolidating after last weeks gains. Trading volume was again light. Leading stocks continue to hold their own and now include biotechs, midcaps and small caps. I had buy signals on speculative stocks ABMD, OVAS, and DPLO – none of which I bought. Both ABMD and DPLO gave no safe […]
Get long Alibaba.Wall Street’s sales traders are increasingly telling clients to buy Alibaba Group Holdings (ticker: BABA) at a time when the stock and associated implied volatility are trading near lows.The recommendation is gaining vigor since the…
Link –
Alibaba: Pessimism Is at Extreme Levels for Stock – Barron's
[…]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
Stock Trading Alert: Slightly Negative Expectations Following Last Week’s RallyBy: Paul Rejczak | Mon, Mar 23, 2015SharePrintEmailStock Trading Alert originally published on March 23, 2015, 7:18 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook (next 1-3 months): […]
